EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
EyePoint, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.44−2.55 (-85.28%)
Close on Oct 19, 2026
- Market cap
- $38.08K
- P/E (TTM)
- –
- Dividend yield
- –
EyePoint, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License and Collaboration Agreements [Member] | $507.00K | $88.00K | $203.00K | $150.00K | $5.33M | $11.05M | $10.59M | $9.56M | $7.78M | $10.56M | $13.03M | $14.14M | 100.0% | -90.5% |
| Royalty Income [Member] | $0 | $141.00K | $118.00K | $234.00K | $0 | $12.69M | $224.00K | $299.00K | $627.00K | $463.00K | $250.00K | $249.00K | 0.0% | – |
| Product [Member] | $0 | $467.00K | $299.00K | $582.00K | $0 | $715.00K | $774.00K | $664.00K | $1.07M | $658.00K | $749.00K | $816.00K | 0.0% | – |
| YUTIQ [Member] | – | – | – | – | – | $600.00K | $700.00K | $700.00K | $1.10M | $700.00K | $800.00K | $800.00K | – | – |
By region
From the segment and revenue-disaggregation notes of EyePoint's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.